NCT05286255View on ClinicalTrials.gov

Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
COVID-19 PneumoniaViral Pneumonia
Interventions
BIOLOGICAL

Allogeneic Mesenchymal Stromal Cells

Intravenous MSCs 1.2-1.5 x 10\^6 cells/kg on Days 1 and 3 after study enrollment

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

Sponsors
All Listed Sponsors
collaborator

Pandorum International, Inc.

UNKNOWN

lead

Medical University of South Carolina

OTHER

NCT05286255 - Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias | Biotech Hunter | Biotech Hunter